HCPCS Level II · Outpatient PPS (temporary codes)
C9146Injection, mirvetuximab soravtansine-gynx, 1 mg
Terminated 06/30/2023
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9146
C9146 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, mirvetuximab soravtansine-gynx, 1 mg.
It was added to HCPCS effective 04/01/2023, and its current record took effect 07/01/2023.
It was terminated on 06/30/2023 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Inj, elahere, 1 mg
- Date added
- 04/01/2023
- Action effective
- 07/01/2023
- Termination date
- 06/30/2023
- BETOS
- O1E
Related C91xx codes
Common questions about C9146
Is HCPCS C9146 still valid?
- No. C9146 was terminated on 06/30/2023.
Does Medicare cover C9146?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.